Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission
about
The Potential for Misuse and Abuse of Medications in ADHD: A ReviewAmphetamine, past and present--a pharmacological and clinical perspectiveAgonist replacement for stimulant dependence: a review of clinical researchBehavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits.Unusual effects of nicotine as a psychostimulant on ambulatory activity in miceAcute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET studyPharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder.The antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model.Agonist replacement therapy for cocaine dependence: a translational review.miRNA-221-3p Enhances the Secretion of Interleukin-4 in Mast Cells through the Phosphatase and Tensin Homolog/p38/Nuclear Factor-kappaB PathwayRepeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate.A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorderMisuse of Methylphenidate.Brain regions and monoaminergic neurotransmitters that are involved in mouse ambulatory activity promoted by bupropion.Fatigue-related impairments in oculomotor control are prevented by norepinephrine-dopamine reuptake inhibition.Psychological and physiological effects of bupropion compared to methylphenidate after prolonged administration in healthy volunteers (NCT00285155).Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice.A dopamine/noradrenaline reuptake inhibitor improves performance in the heat, but only at the maximum therapeutic dose.
P2860
Q22241206-EFE2BC9B-3771-4B65-B67F-E8F586D29A26Q22241826-D3585488-5A7A-4E1D-82EC-A1D02BAC1EB6Q27014854-4AEA2B7F-4534-4FD2-AD41-D02F6CACC6D1Q30454614-B952601F-E084-47E3-868B-A7749581CE70Q30468347-0E1FA63D-A6B5-4409-BCCF-5FFC349F4B18Q34054242-3B1FFADB-6A4A-4B4B-97D1-E75B802613FAQ34251275-52C1176B-4F38-4D16-8AFB-801D86AA9012Q35080134-4FE7E3A9-8BC9-4F65-A2EF-DDDDF7F5F5AEQ35799846-AE4C0A8C-B44B-47F1-B692-A775474487C9Q35930965-0E4495A1-7A25-4A41-BBDD-3B372E41CCB6Q36291652-B5A51E9E-F11A-43FD-A124-292B58EAA044Q36630601-F0668630-ADF7-457F-AC8F-C90E8679CAFAQ40180283-89FAE227-B069-4DE7-8922-462285D09FFFQ41679403-39E46242-DB82-4DF5-93C1-9B7028BC72B1Q41788244-64B3ABB5-0FE8-4E6C-B37E-388319EFB31FQ43705264-D6EAA48B-B12B-46FA-A036-81068F8B5635Q46082611-9BDE606E-F453-4886-8B7C-310CB4FAD217Q47970471-A6E40439-B1B9-49A1-B85D-82BE4B761FC2
P2860
Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Comparisons between bupropion ...... ring dopaminergic transmission
@ast
Comparisons between bupropion ...... ring dopaminergic transmission
@en
type
label
Comparisons between bupropion ...... ring dopaminergic transmission
@ast
Comparisons between bupropion ...... ring dopaminergic transmission
@en
prefLabel
Comparisons between bupropion ...... ring dopaminergic transmission
@ast
Comparisons between bupropion ...... ring dopaminergic transmission
@en
P2860
P356
P1476
Comparisons between bupropion ...... ring dopaminergic transmission
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0707151
P407
P577
2007-02-12T00:00:00Z